Intravascular Ultrasound Market (By Modality: iMAP, Virtual Histology; By Product: Consoles, Accessories; By End-use: Hospitals, Diagnostic Imaging Centers) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Intravascular Ultrasound Market 

5.1. COVID-19 Landscape: Intravascular Ultrasound Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Intravascular Ultrasound Market, By Modality

8.1. Intravascular Ultrasound Market, by Modality, 2022-2030

8.1.1 Virtual Histology IVUS

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. iMap IVUS

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Integrated Backscatter IVUS

8.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Intravascular Ultrasound Market, By Product

9.1. Intravascular Ultrasound Market, by Product, 2022-2030

9.1.1. Consoles

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Accessories

9.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Intravascular Ultrasound Market, By End-use 

10.1. Intravascular Ultrasound Market, by End-use, 2022-2030

10.1.1. Hospitals

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Diagnostic Imaging Centers

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Academic & Research Institutes

10.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Intravascular Ultrasound Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Modality (2017-2030)

11.1.2. Market Revenue and Forecast, by Product (2017-2030)

11.1.3. Market Revenue and Forecast, by End-use (2017-2030)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Modality (2017-2030)

11.1.4.2. Market Revenue and Forecast, by Product (2017-2030)

11.1.4.3. Market Revenue and Forecast, by End-use (2017-2030)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Modality (2017-2030)

11.1.5.2. Market Revenue and Forecast, by Product (2017-2030)

11.1.5.3. Market Revenue and Forecast, by End-use (2017-2030)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Modality (2017-2030)

11.2.2. Market Revenue and Forecast, by Product (2017-2030)

11.2.3. Market Revenue and Forecast, by End-use (2017-2030)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Modality (2017-2030)

11.2.4.2. Market Revenue and Forecast, by Product (2017-2030)

11.2.4.3. Market Revenue and Forecast, by End-use (2017-2030)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Modality (2017-2030)

11.2.5.2. Market Revenue and Forecast, by Product (2017-2030)

11.2.5.3. Market Revenue and Forecast, by End-use (2017-2030)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Modality (2017-2030)

11.2.6.2. Market Revenue and Forecast, by Product (2017-2030)

11.2.6.3. Market Revenue and Forecast, by End-use (2017-2030)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Modality (2017-2030)

11.2.7.2. Market Revenue and Forecast, by Product (2017-2030)

11.2.7.3. Market Revenue and Forecast, by End-use (2017-2030)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Modality (2017-2030)

11.3.2. Market Revenue and Forecast, by Product (2017-2030)

11.3.3. Market Revenue and Forecast, by End-use (2017-2030)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Modality (2017-2030)

11.3.4.2. Market Revenue and Forecast, by Product (2017-2030)

11.3.4.3. Market Revenue and Forecast, by End-use (2017-2030)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Modality (2017-2030)

11.3.5.2. Market Revenue and Forecast, by Product (2017-2030)

11.3.5.3. Market Revenue and Forecast, by End-use (2017-2030)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Modality (2017-2030)

11.3.6.2. Market Revenue and Forecast, by Product (2017-2030)

11.3.6.3. Market Revenue and Forecast, by End-use (2017-2030)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Modality (2017-2030)

11.3.7.2. Market Revenue and Forecast, by Product (2017-2030)

11.3.7.3. Market Revenue and Forecast, by End-use (2017-2030)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Modality (2017-2030)

11.4.2. Market Revenue and Forecast, by Product (2017-2030)

11.4.3. Market Revenue and Forecast, by End-use (2017-2030)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Modality (2017-2030)

11.4.4.2. Market Revenue and Forecast, by Product (2017-2030)

11.4.4.3. Market Revenue and Forecast, by End-use (2017-2030)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Modality (2017-2030)

11.4.5.2. Market Revenue and Forecast, by Product (2017-2030)

11.4.5.3. Market Revenue and Forecast, by End-use (2017-2030)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Modality (2017-2030)

11.4.6.2. Market Revenue and Forecast, by Product (2017-2030)

11.4.6.3. Market Revenue and Forecast, by End-use (2017-2030)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Modality (2017-2030)

11.4.7.2. Market Revenue and Forecast, by Product (2017-2030)

11.4.7.3. Market Revenue and Forecast, by End-use (2017-2030)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Modality (2017-2030)

11.5.2. Market Revenue and Forecast, by Product (2017-2030)

11.5.3. Market Revenue and Forecast, by End-use (2017-2030)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Modality (2017-2030)

11.5.4.2. Market Revenue and Forecast, by Product (2017-2030)

11.5.4.3. Market Revenue and Forecast, by End-use (2017-2030)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Modality (2017-2030)

11.5.5.2. Market Revenue and Forecast, by Product (2017-2030)

11.5.5.3. Market Revenue and Forecast, by End-use (2017-2030)

Chapter 12. Company Profiles

12.1. Canon Medical Systems Corp.

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Boston Scientific Corp.

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. GE Healthcare

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Philips

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Siemens Healthcare

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Hitachi

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Mindray Medical International Ltd.

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Fujifilm Corp.

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Samsung Medison

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Chison Medical Technologies

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Report Detail

Proceed To Buy

USD 3500
USD 7000